Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by toniZ1on Mar 24, 2022 1:52pm
112 Views
Post# 34542299

RE:RE:RE:Very Disturbing

RE:RE:RE:Very Disturbinglol...the company is since years close to bankruptcy and always delays only. they have no income stream and so relay only on the capital market - any successfull financing is a good news ;-)

they have a working tec but not the ressources to push it forward. shiseido has the ressources, has built (based on this tec) a product, has setup a research lab and has run the related studies, but does not own the tec. shiseido has decided not to work with replicel anymore. so what is this all about? is it rational for shiseido to do all those these things and then drop everything? they committed several times that they are going this route, e.g.:

Thus, concerned persons look forward to the technology being widely utilized as soon as possible.
Safety level and improvement effects were confirmed in a clinical study conducted by Tokyo Medical University and other university institutes from 2016 to 2019 using our autologous cell culture processing technology.
Currently a further clinical study is being carried out aiming at practical application. 


New research areas | Research Areas | INNOVATION | Shiseido Company

From my point of view Shiseido is close to market entry with RCH-01, maybe 1-2 years away. The abritation will speed things up with a definitive outcome by this year. That's why I re-entered the game. 

Yofoto - the only thing I am aware of was that they had setup a lab. If I take a look at their webiste I really wonder how cell therapies fits their portfolio. Won't expect much in the short term... but hey they payed 0.95 four years ago....

Dermal Injector - test, optimize, test, optimize, test, optimize.... how long this will continue? Doesn't look like rocket sience but seems to take the same amount of time... also don't see a big rush for this product and also don't see that they have any product ready to be sold as injectable...  Won't expect much in the short term...

Trades are trades hehe, thats true. but there are big sell/buy orders or simply garbage trades as seen today. For small money you can move the stock also upwards...

I know I am unknown here... I invested earlier than you, sadly, it has become nearly worthless. Shiseido was the trigger for me to throw a bit more money in here as I see the buy-out very likley. If that happens and we get 5-10 USD/share, we can be happy - thats the best outcome possible from my point of view. 

Anything else is years away and that means simply bankruptcy or massive dillution, as there is no income stream and no money in the bank. 
<< Previous
Bullboard Posts
Next >>